Key statistics
On Friday, Cytek Biosciences Inc (CTKB:NSQ) closed at 4.43, -28.32% below its 52-week high of 6.18, set on Nov 17, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 4.30 |
|---|---|
| High | 4.44 |
| Low | 4.24 |
| Bid | 4.30 |
| Offer | 4.57 |
| Previous close | 4.34 |
| Average volume | 941.22k |
|---|---|
| Shares outstanding | 127.86m |
| Free float | 116.00m |
| P/E (TTM) | -- |
| Market cap | 554.93m USD |
| EPS (TTM) | -0.1011 USD |
Data delayed at least 15 minutes, as of Feb 20 2026 21:00 GMT.
More ▼
- TIME Recognizes Cytek® Biosciences as One of America’s Growth Leaders of 2026
- Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year
- Cytek® Biosciences Deepens Commitment to Expanding Access to Flow Cytometry
- Cytek® Biosciences Expands European Presence with New Facility in Amsterdam to Better Serve Customers and Drive Growth
- Cytek Biosciences Brings Full Spectrum Cell Analysis to Leading Clinical Global Conferences ICCS and ESCCA
- Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer
- Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025
- Cytek® Biosciences Expands Cell Analysis Offerings with the Affordable, User-Friendly Cytek® Muse® Micro System
More ▼
